Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4 — Billings, Montana

Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4 is a clinical research site located in Billings, Montana, United States 59101.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4 has participated in 1 clinical trials.

Therapeutic areas: First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4?

Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4 conducted?

Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4 has 1 clinical trials on record. Their work covers First or Second Line HER2-negative Breast Cancer, Metastatic Disease Without Bone Metastasis.

Is Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4 accredited by Crixeo Health?

Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hematology Oncology Centers of the Northern Rockies Hema Onc Ctr N. Rockies (4?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.